
Project details
Japanese functional protein production company seeks Chinese partners.
Project region | Japan |
---|---|
Industry | Biomedicine |
Total value of the target | N/A |
Expected target net rate of return after deducting all taxes and fees | N/A |
Validity period of pending order | 365 |
CONTACT ADVISOR
Project highlights | genome editing tech - A-round USD 6.2 million - B-Round USD 10 m target |
---|---|
Project description |
The Japanese company uses genome editing technology to extract functional proteins from farmed chickens and provide them as pharmaceutical raw materials to antibody, vaccine and other pharmaceutical companies. The CTO and CSO are the active professor and associate professor of the University of Tokushima respectively. The company completed A-round financing of USD 6.2 million in 2020 and plans to launch B-round financing of USD 10 million in the near future. It hopes to establish cooperative relations with relevant Chinese enterprises and obtain Chinese investment. |

We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.
Have Any Questions?
Reach out to our local experts, we’ll respond within one business day.
Our Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us